EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Potential drug-drug interactions in hospitalized patients with acute coronary syndrome at a tertiary care hospital in upper Egypt

Ayad A Ghabesha, Sahar B Hassan, Hosam Hasan-Ali, Mohamed M M Abdel-Latif

Frontiers in Pharmacology · 14.04.2026 · 17

DOI: 10.3389/fphar.2026.1761758 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 14.04.2026. Verfasst von Ayad A Ghabesha und 3 weiteren Autor:innen. Beteiligte Einrichtung: Ministry of Health and Population, Aden, Yemen. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Potential drug-drug Interactions (pDDIs) are a serious concern in cardiovascular patients and are responsible for most adverse drug reactions and drug-related hospital admissions. Clinically significant pDDIs may injure patients, create adverse outcomes, and impact healthcare costs. Therefore, pDDIs control is critical for the improvement of prescription drug safety.

Aim

The present study aimed to assess potential pDDIs among cardiovascular patients at a Tertiary Care Hospital in Upper Egypt.

Methods

A prospective observational study was performed on acute coronary syndrome (ACS) patients attending Assiut University Heart Hospital. The Lexi-Interact online was used to assess pDDIs. Multiple logistic regression was used to identify the factors associated with pDDIs.

Results

A total of 371 patients attending Assiut University Heart Hospital were recruited for the study. A total of 2,504 pDDIs were detected among the patients. The mean number of drugs prescribed per patient was 7.78 ± 1.73. Class C, D, and X DDIs were found in 74.76%, 10.02%, and 0.04%, respectively. Aspirin and ticagrelor were the most prevalent pDDIs under category D (232, 92.4%). A combination of ramipril and aspirin was the most frequently encountered interacting pair in the class C (281, 17.2%). STEMI patients, length of hospital stay, and a higher number of prescribed drugs were significantly associated with the occurrence of pDDIs, according to multiple logistic regression.

Conclusion

Patients with ACS were frequently exposed to pDDIs with the highest drug-related problems, treatment failure, and negative consequences. Therefore, clinical pharmacists ought to be more involved in managing complex drug regimens and improving therapeutic outcomes.

Schlagwörter

Stichwörter der Autor:innen

Egyptianacute coronary syndromedrug therapydrug-drug interactionsdrug-related problem

Autor:innen und Institutionen

  • Ministry of Health and Population, Aden, Yemen.
  • Department of Clinical Pharmacy, Faculty of Pharmacy, Assiut University, Assiut, Egypt.
  • Department of Cardiovascular Medicine, Faculty of Medicine, Assiut University, Assiut, Egypt.

Zitieren

APA

Ghabesha, A. A., Hassan, S. B., Hasan-Ali, H., & Abdel-Latif, M. M. M. (2026). Potential drug-drug interactions in hospitalized patients with acute coronary syndrome at a tertiary care hospital in upper Egypt. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1761758

Vancouver

Ghabesha AA, Hassan SB, Hasan-Ali H, Abdel-Latif MMM. Potential drug-drug interactions in hospitalized patients with acute coronary syndrome at a tertiary care hospital in upper Egypt. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1761758

BibTeX
@article{Ghabesha2026,
  author = {Ghabesha, Ayad A and Hassan, Sahar B and Hasan-Ali, Hosam and Abdel-Latif, Mohamed M M},
  title = {Potential drug-drug interactions in hospitalized patients with acute coronary syndrome at a tertiary care hospital in upper Egypt},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1761758}
}
Kostenlos starten →